| Literature DB >> 30608546 |
Mengfei Liu1, Zhonghu He1, Chuanhai Guo1, Ruiping Xu2, Fenglei Li3, Tao Ning1, Yaqi Pan1, Yong Li1, Huirong Ding1, Li Zheng1, Yue Zhou1, Xiuyun Tian1, Wenjun Yang1, Xueqian Wang1, Fang Lu1, Yanyan Zhang1, Yiqiang Zhao1, Fangcen Guo1, Ke Chen1, Lei Gao1, Min Sun1, Ying Liu1, Fangfang Liu1, Dong Hang1, Na Shen1, Jingjing Li1, Zhongyao Xu1, Qiyan Wang1, Chanyuan Zhang1, Amir Abliz1, Qiuju Deng1, Xiang Li1, Zhen Liu1, Chaoting Zhang1, Wenqing Yuan1, Hui Wang1, Noel S Weiss4, Hong Cai1, Yang Ke1.
Abstract
Evidence is required to evaluate the effectiveness of population-level endoscopic screening for esophageal cancer (EC). In this study, 5,632 permanent residents aged 25-65 years from 6 villages in Hua County, Henan Province, China, were defined as the screening cohort and were offered intensive endoscopic screening. Residents of all 914 remaining villages in Hua County were included as the control cohort, and age-sex standardization was used to calculate the expected numbers of EC and upper gastrointestinal (GI) tract cancer cases and deaths in the screening cohort. The effectiveness of screening was assessed by comparing observed numbers of cases and deaths with expected numbers after 9-year follow-up of these screened subjects (2007-2016). In the screening cohort, 23 upper GI cancers (including 16 ECs) and 10 upper GI cancer deaths (including 5 EC deaths) were identified, and 47% (standardized incidence ratio = 0.53, 95% confidence interval (CI): 0.33, 0.87) and 66% (standardized mortality ratio = 0.34, 95% CI: 0.14, 0.81) reductions in cumulative EC incidence and mortality were found. For upper GI cancers, incidence and mortality were lowered by 43% (standardized incidence ratio = 0.57, 95% CI: 0.38, 0.86) and 53% (standardized mortality ratio = 0.47, 95% CI: 0.25, 0.88), respectively. This study showed that upper GI tract endoscopy is an effective population-level screening test for EC in high-risk regions.Entities:
Keywords: China; endoscopy; esophageal cancer; esophageal squamous cell carcinoma; population-based endoscopic screening
Mesh:
Year: 2019 PMID: 30608546 DOI: 10.1093/aje/kwy291
Source DB: PubMed Journal: Am J Epidemiol ISSN: 0002-9262 Impact factor: 4.897